Bactolife A/S

BiotechnologySeries BCopenhagen, Denmarkbactolife.com

Latest round

Series B

Last raised

Jan 2026

Total raised

$68M

Investors

5

About Bactolife A/S

Based in Copenhagen, Denmark, and founded in 2017, Bactolife A/S is a company that offers a technology platform to develop Binding Proteins™, a biological solution for gut health. The company was co-founded by Mads Laustsen (CEO), Andreas H. Laustsen-Kiel (CTO), Sandra Wingaard Thrane (CSO), and Per Falholt (Board member). Bactolife’s Binding Proteins™ provide specialty food/feed ingredients and dietary supplements to reduce the risk of gut health infections in humans and animals, without targeting growth or killing the bacteria directly but by neutralising the toxins produced by the harmful microbes. The firm’s solution can be incorporated into a wide variety of formulations, has highly versatile natural ingredients, and is stable with respect to temperature and pH resistance. Bactolife mainly serves mothers and children, the elderly, the immunodeficient, travellers, the deployed, and animal health. Bactolife A/S generates revenues from B2B ingredient sales (Helm™) to CPG, dietary supplement, and animal nutrition partners, complemented by co-development/licensing partnerships and non-dilutive grants supporting platform development.

Who invested in Bactolife A/S

5 investors across 2 rounds

See all investors in Bactolife A/S

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jan 6, 2026

    Amount

    $35M

    Investors

    Locked

  2. Series A

    Aug 8, 2023

    Amount

    $33M

    Investors

    Locked

Questions about Bactolife A/S

Who invested in Bactolife A/S?

Bactolife A/S has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Bactolife A/S raised?

Bactolife A/S has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Bactolife A/S last raise money?

Bactolife A/S's most recent round on record is a Series B, in Jan 2026.

What does Bactolife A/S do?

Based in Copenhagen, Denmark, and founded in 2017, Bactolife A/S is a company that offers a technology platform to develop Binding Proteins™, a biological solution for gut health.

Where is Bactolife A/S headquartered?

Bactolife A/S is headquartered in Copenhagen, Denmark.

Which VCs invest in companies like Bactolife A/S?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Bactolife A/S's stage. Their profiles are linked below.

Raising like Bactolife A/S? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.